Cargando…
Treatment of early arthritis using arthrofoon (ultra-low doses of antibodies to tumor necrosis factor-α)
The main aim of treatment of early rheumatoid arthritis (RA) should be to achieve clinical remission to prevent structural damage and physical disability. Arthrofoon modifies production/activity of endogenous inhibitors of tumor necrosis factor-α (TNF-α). The sublingual rout is the most acceptable t...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Medknow Publications & Media Pvt Ltd
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3229795/ https://www.ncbi.nlm.nih.gov/pubmed/22144784 http://dx.doi.org/10.4103/0253-7613.89836 |